These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 33277847)

  • 1. Changes in tumor markers, coagulation function and serum VEGF in patients with ovarian cancer and benign ovarian disease.
    Wang J; Zhu M; Zhou X; Wang T; Zhang J
    J BUON; 2020; 25(5):2287-2292. PubMed ID: 33277847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noninvasive evaluation of ovarian endometriosis: a single-center experience.
    Zhao K; Qu P
    Ann Palliat Med; 2021 Apr; 10(4):4728-4735. PubMed ID: 33966422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular endothelial growth factor (VEGF) improves the sensitivity of CA125 for differentiation of epithelial ovarian cancers from ovarian cysts.
    Robati M; Ghaderi A; Mehraban M; Shafizad A; Nasrolahi H; Mohammadianpanah M
    Arch Gynecol Obstet; 2013 Oct; 288(4):859-65. PubMed ID: 23564055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The diagnostic accuracy of two human epididymis protein 4 (HE4) testing systems in combination with CA125 in the differential diagnosis of ovarian masses.
    Lenhard M; Stieber P; Hertlein L; Kirschenhofer A; Fürst S; Mayr D; Nagel D; Hofmann K; Krocker K; Burges A
    Clin Chem Lab Med; 2011 Sep; 49(12):2081-8. PubMed ID: 21923475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of HE4, CA125, risk of ovarian malignancy algorithm (ROMA) and risk of malignancy index (RMI) as diagnostic tools of epithelial ovarian cancer in patients with a pelvic mass.
    Karlsen MA; Sandhu N; Høgdall C; Christensen IJ; Nedergaard L; Lundvall L; Engelholm SA; Pedersen AT; Hartwell D; Lydolph M; Laursen IA; Høgdall EV
    Gynecol Oncol; 2012 Nov; 127(2):379-83. PubMed ID: 22835718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Research on the coagulation function changes in non small cell lung cancer patients and analysis of their correlation with metastasis and survival.
    Qi Y; Fu J
    J BUON; 2017; 22(2):462-467. PubMed ID: 28534370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis of the factors associated with abnormal coagulation and prognosis
 in patients with non-small cell lung cancer].
    Li Y; Wei S; Wang J; Hong L; Cui L; Wang C
    Zhongguo Fei Ai Za Zhi; 2014 Nov; 17(11):789-96. PubMed ID: 25404269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum Vascular Endothelial Growth Factor-A as a Prognostic Biomarker for Epithelial Ovarian Cancer.
    Komatsu H; Oishi T; Itamochi H; Shimada M; Sato S; Chikumi J; Sato S; Nonaka M; Sawada M; Wakahara M; Umekita Y; Harada T
    Int J Gynecol Cancer; 2017 Sep; 27(7):1325-1332. PubMed ID: 28557832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative serum vascular endothelial growth factor (VEGF) in ovarian masses.
    Tanir HM; Ozalp S; Yalcin OT; Colak O; Akcay A; Senses T
    Eur J Gynaecol Oncol; 2003; 24(3-4):271-4. PubMed ID: 12807238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Relationship between coagulation function and international prognostic index in lymphoma patients].
    Jiang YJ; Li XM; Han XH; Zhu GH; Zhuang WC; Gu J; Kang LL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1489-93. PubMed ID: 21176357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiogenic and coagulation-fibrinolysis factors in non Hodgkin's lymphoma.
    Wróbel T; Poreba M; Mazur G; Poreba R; Pyszel A; Beck B; Steinmetz-Beck A; Andrzejak R; Kuliczkowski K
    Neoplasma; 2006; 53(3):253-8. PubMed ID: 16652197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of serum VEGF levels with clinical stage, therapy efficacy, tumor metastasis and patient survival in ovarian cancer.
    Li L; Wang L; Zhang W; Tang B; Zhang J; Song H; Yao D; Tang Y; Chen X; Yang Z; Wang G; Li X; Zhao J; Ding H; Reed E; Li QQ
    Anticancer Res; 2004; 24(3b):1973-9. PubMed ID: 15274387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Hypercoagulable State for Predictive Ovarian Malignancy in Women with a Pelvic Mass.
    Yanaranop M
    J Med Assoc Thai; 2017 Feb; 100 Suppl 1():S148-56. PubMed ID: 29927556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical value of TV-CDS combined with serum tumor markers in diagnosis of ovarian cancer.
    Yu C; Dou T; Liu Y; Liu R
    Oncol Lett; 2020 Aug; 20(2):2028-2034. PubMed ID: 32724450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic Performance of Risk of Ovarian Malignancy Algorithm Against CA125 and HE4 in Connection With Ovarian Cancer: A Meta-analysis.
    Dayyani F; Uhlig S; Colson B; Simon K; Rolny V; Morgenstern D; Schlumbrecht M
    Int J Gynecol Cancer; 2016 Nov; 26(9):1586-1593. PubMed ID: 27540691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role and clinical significance of coagulation and inflammatory factors in moderate and severe ovarian endometriosis].
    Lin Q; Ding SJ; Zhu TH; Li TT; Huang XF; Zhang XM
    Zhonghua Fu Chan Ke Za Zhi; 2018 Mar; 53(3):167-171. PubMed ID: 29609230
    [No Abstract]   [Full Text] [Related]  

  • 17. Preoperative serum vascular endothelial growth factor levels: significance in ovarian cancer.
    Cooper BC; Ritchie JM; Broghammer CL; Coffin J; Sorosky JI; Buller RE; Hendrix MJ; Sood AK
    Clin Cancer Res; 2002 Oct; 8(10):3193-7. PubMed ID: 12374688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum VEGF, P-Selectin, HDL-C, Platelet Index, and Coagulation Function Index in Deep Vein Thrombosis after Traumatic Fracture.
    Gu H; Yang F; Xie H; Li M; Wang Z; Sheng L
    Clin Lab; 2024 Feb; 70(2):. PubMed ID: 38345981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Changes of coagulation function in patients with adenomyosis].
    Zhang HY; Wang AQ; Zhu S; Yu L; Sun JF; Xu W; Wang XL
    Zhonghua Fu Chan Ke Za Zhi; 2022 Mar; 57(3):179-189. PubMed ID: 35385955
    [No Abstract]   [Full Text] [Related]  

  • 20. [Vascular endothelial growth factor in ovarian cancer patients].
    Sedláková I; Tošner J; Kopecký O; Vroblová V; Rezáč A; Skapinec P; Andrýs C
    Ceska Gynekol; 2012 Oct; 77(5):415-20. PubMed ID: 23116346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.